OptiNose’s innovative approach enables broad, consistent drug delivery deep in the nasal cavity, leveraging the mucosal surfaces as a potent target for the treatment of both local and systemic diseases using a Bi-Directional™ Breath Powered® technology, the Exhalation Delivery System platform offers a much-needed alternative to traditional nasal inhalers, as well as to tablets and injections.

How the Exhalation Delivery System Works

Novel Devices with Vast Commercial and Clinical Potential

The patient-friendly Exhalation Delivery Systems transcend the limitations of traditional nasal sprays, which have been limited primarily to treating the common cold and nasal allergies. The technology platform is also a highly versatile alternative to oral and injected delivery of medicines and vaccines. Suitable for powder and liquid formulations, it has the potential to:

  • Produce reliable dosing
  • Improve patient compliance and delivery success
  • Allow patients to self-medicate
  • Reduce risks of needle-stick injuries
  • Minimize local irritation